Rapid development of a DNA vaccine for zika virus
Autor(es): Dowd, Kimberly A. ; Sung-Youl Ko ; Morabito, Kaitlyn M. ; Eun Sung Yang ; Pelc, Rebecca S. ; DeMaso, Christina R. ; Castilho, Leda R. Castilho ; Abbink, Peter ; Boyd, Michael ; Nityanandam, Ramya ; Gordon, David N. Gordon ; Gallagher, John Robert ; Chen, Xuejun Chen ; Todd, John-Paul ; Tsybovsky, Yaroslav ; Harris, Audray ; Huang, Yan-Jang S. ; Higgs, Stephen ; Vanlandingham, Dana L. ; Andersen, Hanne ; Lewis, Mark G. ; Barrera, Rafael De La ; Eckels, Kenneth H. ; Jarmn, Richard G. ; Nason, Martha C. Nason ; Barouch, Dan H. ; Roederer, Mario Roederer ; Kong, Wing-Pui ; Mascola, John R. ; Pierson, Theodore C. ; Grahan, Barney S.
Resumo: Zika virus (ZIKV) was identified as a cause of congenital disease during an explosive outbreak in the Americas and Caribbean in 2015. Because of the ongoing fetal risk from endemic disease and travel-related exposures, a vaccine to prevent viremia in women of child-bearing age and their partners is imperative. Vaccination with DNA expressing the prM and E proteins of ZIKV was immunogenic in mice and nonhuman primates, and protection against viremia after ZIKV challenge correlated with serum neutralizing activity. These data not only indicate DNA vaccination could be a successful approach to protect against ZIKV infection, but also suggest a protective threshold of vaccine-induced neutralizing activity that will prevent viremia following acute infection
Imprenta: Science, v. 354, n. 6316 , 2016
Identificador do objeto digital: 10.1126/science.aai9137
Descritores: Zika virus - Viral infections ; Zika virus - Vaccine
Data de publicação: 2016
